Raymond H. Kim — Endo Lab

observational 2025

Endometriosis in Carriers of a Pathogenic Variant in BRCA1 or BRCA2: A Descriptive Analysis of a Large Multicentral BRCA Carrier Cohort

Current oncology (Toronto, Ont.) ·doi:10.3390/curroncol32120675

Background: Endometriosis affects an estimated 10% of reproductive-aged women and is associated with increased ovarian cancer risk. While BRCA1/2 mutations are established risk factors for ovarian cancer, their association with endometriosi…

observational 2025

Hormonal Contraception and Breast Cancer Risk for Carriers of Germline Mutations in BRCA1 and BRCA2

Journal of Clinical Oncology ·doi:10.1200/jco.24.00176

PURPOSE: It is uncertain whether, and to what extent, hormonal contraceptives increase breast cancer (BC) risk for germline BRCA1 or BRCA2 mutation carriers. METHODS: Using pooled observational data from four prospective cohort studies, as…

nonrandomized-trial 2025

P-751 Fertility and clinical efficacy outcome of a novel method of fertility-preserving adenomyomectomy in infertile women with uterine adenomyosis

·doi:10.1093/humrep/deaf097.1056

Abstract Study question Does surgical removal of adenomyosis have clinical efficacy in infertile women? Summary answer Modified adenomyomectomy as a uterus-sparing surgery could be an effective method for increasing pregnancy rate and conse…